These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 401461)

  • 1. An evaluation of the in vivo properties of 99mTc-HEDP.
    Citrin DL
    Radiology; 1977 Jan; 122(1):255-8. PubMed ID: 401461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 99mTc-labelled polyphosphate, pyrophosphate and ethane hydroxy diphosphonate in patients with skeletal metastases and in normal subjects.
    Citrin DL; Bessent RG; Tuohy JB; Elms ST; McGinlay E; Greig WR; Blumgart LH
    Strahlentherapie Sonderb; 1975; 74():321-8. PubMed ID: 173049
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
    Tofe AJ; Francis MD; Harvey WJ
    J Nucl Med; 1975 Nov; 16(11):986-9. PubMed ID: 810549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two different HEDP content kits: stability study against dilution both in vivo and in vitro.
    Inoue O; Ikeda I; Kurata K
    Nuklearmedizin; 1982 Jun; 21(3):121-5. PubMed ID: 6813826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ; Francis MD
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative investigations concerning osteotropic radiopharmaceuticals. III. Scanning with 18F and 99mTc-malignant diseases (author's transl)].
    Creutzig H
    Rofo; 1975 Nov; 123(5):462-7. PubMed ID: 128507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
    Citrin DL; Bessent RG; McGinley E; Gordon D
    J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of some phosphorus bone-imaging agents: concise communication.
    Nelson MF; Clifford McKee L; Van Wazer JR
    J Nucl Med; 1977 Jun; 18(6):566-9. PubMed ID: 404405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What causes lower neck uptake in bone scans?
    Oppenheim BE; Cantez S
    Radiology; 1977 Sep; 124(3):749-52. PubMed ID: 196313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone scintigraphy as a guide to the diagnosis of osteoid osteoma.
    Mallens WM; Pauwels EK; Tetteroo QF
    Radiol Clin (Basel); 1977; 46(4):300-6. PubMed ID: 406640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic inhibition of diphosphonate: a proposed mechanism of tissue uptake.
    Zimmer AM; Isitman AT; Holmes RA
    J Nucl Med; 1975 May; 16(5):352-6. PubMed ID: 811772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technetium polyphosphate and technetium diphosphonate. A comparative study].
    Henne W; Pixberg HU; Pfannenstiel P
    Nucl Med (Stuttg); 1975 Jun; 14(2):83-90. PubMed ID: 1178518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scan analysis in myocardial infarction.
    Ell PJ
    Nuklearmedizin; 1976 Aug; 15(4):157-9. PubMed ID: 824624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc pyrophosphate for diagnostic bone imaging.
    Weber DA; Keyes JW; Benedetto WJ; Wilson GA
    Radiology; 1974 Oct; 113(1):131-7. PubMed ID: 4370746
    [No Abstract]   [Full Text] [Related]  

  • 20. The reliability of 99mmTc-pyrophosphate scintigraphy in the diagnosis of bony metastases.
    Nordman E; Marjamäki H; Tannila O
    Ann Clin Res; 1977 Feb; 9(1):31-4. PubMed ID: 883754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.